About 130 family office decision-makers and affluent second-generation members from across the world attended a dinner held by the Hong Kong government on Monday evening, including billionaire Pop Mart founder, chairman and CEO Wang Ning. The dinner set the stage for the fourth edition of the Wealth for Good in Hong Kong (WGHK) Summit, themed…
Hong Kong-listed Insilico Medicine has signed a cooperation agreement with the United Arab Emirates’ drug regulator to advance the use of its artificial intelligence tools in drug discovery across the region, even as geopolitical tensions escalate in the Middle East. Shares of Insilico rose as much as 12.8 per cent in morning trading on Thursday…
Mainland China and Hong Kong should ease listing rules for biotechnology companies and lower takeover thresholds for listed firms to capitalise on renewed foreign interest in the healthcare sector, venture capitalist Nisa Leung said. “Besides artificial intelligence, Premier Li Qiang also highlighted biomedicine in the ‘two sessions’ annual government work report,” said Leung, a managing…
The deal comes just days after the US company’s shares debuted following its initial public offering (IPO), which raised HK$2.28 billion (US$293 million) after the public portion was oversubscribed 1,427 times. The multi-year partnership with Servier, unveiled on Saturday, would make Insilico eligible for up to US$32 million in upfront and near-term research and development…
“Biotechnology is a high-risk field like a ‘molecular casino’,” said founder Alex Zhavoronkov. “Even with artificial intelligence, you can lose 90 per cent of the time.” The 11-year-old company was training and testing an AI-powered drug-discovery tool, Pharma.AI, to “enable faster, cheaper and more successful drug discovery with higher novelty and confidence”, he said. Zhavoronkov…
Hong Kong’s initial public offering (IPO) market is heading for its busiest month in four years, as a late rush of listings gathers pace despite the traditional slowdown around the Christmas and New Year holidays. At least 15 companies were set to go public by the end of December, with drug-discovery firm Insilico Medicine planning…